Literature DB >> 19647612

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancy: overview and rationale.

Perry Shen1, John H Stewart, Edward A Levine.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19647612     DOI： 10.1016/j.currproblcancer.2009.06.003

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN： 0147-0272            Impact factor:   3.187


× No keyword cloud information.
  15 in total

Review 1.  Multimodal treatment of gastric cancer in the west: Where are we going?

Authors:  Daniele Marrelli; Karol Polom; Giovanni de Manzoni; Paolo Morgagni; Gian Luca Baiocchi; Franco Roviello
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

2.  Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors.

Authors:  Konstantinos I Votanopoulos; Douglas S Swords; Katrina R Swett; Reese W Randle; Perry Shen; John H Stewart; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2013-06-26       Impact factor: 5.344

3.  Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Reese W Randle; Andrea N Doud; Edward A Levine; Clancy J Clark; Katrina R Swett; Perry Shen; John H Stewart; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2014-08-14       Impact factor: 5.344

4.  Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Andrea N Doud; Reese W Randle; Clancy J Clark; Edward A Levine; Katrina R Swett; Perry Shen; John H Stewart; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2014-08-14       Impact factor: 5.344

5.  Stoma Creation and Reversal After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Andrea N Doud; Edward A Levine; Nora F Fino; John H Stewart; Perry Shen; Konstantinos I Votanopoulos
Journal:  Ann Surg Oncol       Date:  2015-06-16       Impact factor: 5.344

6.  Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy.

Authors:  Konstantinos I Votanopoulos; Chukwuemeka Ihemelandu; Perry Shen; John H Stewart; Gregory B Russell; Edward A Levine
Journal:  J Am Coll Surg       Date:  2012-05-26       Impact factor: 6.113

7.  A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.

Authors:  Konstantinos Votanopoulos; Chukwuemeka Ihemelandu; Perry Shen; John Stewart; Gregory Russell; Edward A Levine
Journal:  J Surg Res       Date:  2012-03-10       Impact factor: 2.192

8.  Significance of urinary tract involvement in patients treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).

Authors:  Konstantinos I Votanopoulos; Reese W Randle; Brandon Craven; Katrina R Swett; Edward A Levine; Perry Shen; John H Stewart; Majid Mirzazadeh
Journal:  Ann Surg Oncol       Date:  2013-11-12       Impact factor: 5.344

9.  Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from rectal cancer.

Authors:  Konstantinos I Votanopoulos; Katrina Swett; Aaron U Blackham; Chukwuemeka Ihemelandu; Perry Shen; John H Stewart; Edward A Levine
Journal:  Ann Surg Oncol       Date:  2013-03-02       Impact factor: 5.344

Review 10.  Cytoreductive surgery and intraperitoneal chemotherapy: an evidence-based review-past, present and future.

Authors:  Ahmed Dehal; J Joshua Smith; Garrett M Nash
Journal:  J Gastrointest Oncol       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.